Stockscreener 앱 받기
27.57
2.03%
-0.57
전일 마감가:
$28.14
열려 있는:
$28.54
하루 거래량:
46,489
Relative Volume:
0.32
시가총액:
$406.58M
수익:
$138.20M
순이익/손실:
$5.52M
주가수익비율:
72.55
EPS:
0.38
순현금흐름:
$9.86M
1주 성능:
+1.21%
1개월 성능:
-4.96%
6개월 성능:
-28.17%
1년 성능:
+3.96%
1일 변동 폭
$27.45
$28.86
1주일 범위
$27.45
$28.86
52주 변동 폭
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
명칭
Surmodics Inc
전화
(952) 500-7000
주소
9924 W 74TH ST, EDEN PRAIRIE, MN
SRDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
27.57 | 406.58M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 업그레이드 | Lake Street | Hold → Buy |
| 2023-06-13 | 업그레이드 | Needham | Hold → Buy |
| 2023-02-13 | 다운그레이드 | Needham | Buy → Hold |
| 2020-07-23 | 업그레이드 | Needham | Hold → Buy |
| 2019-12-11 | 다운그레이드 | Needham | Buy → Hold |
| 2019-11-01 | 다운그레이드 | Lake Street | Buy → Hold |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Lake Street | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-02-21 | 재확인 | Needham | Buy |
| 2018-05-16 | 재확인 | Needham | Buy |
| 2018-03-01 | 업그레이드 | Sidoti | Neutral → Buy |
| 2018-02-28 | 재확인 | Lake Street | Buy |
| 2018-02-28 | 개시 | Needham | Buy |
| 2017-07-14 | 개시 | Lake Street | Buy |
| 2016-11-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-05-03 | 재확인 | Barrington Research | Outperform |
| 2015-08-06 | 재확인 | Barrington Research | Outperform |
| 2015-03-27 | 개시 | Dougherty & Company | Buy |
| 2014-02-25 | 개시 | Laidlaw | Buy |
| 2013-08-01 | 업그레이드 | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | 재확인 | Barrington Research | Outperform |
모두보기
Surmodics Inc 주식(SRDX)의 최신 뉴스
Illinois joins FTC suit to block GTCR’s takeover of Surmodics - Crain's Chicago Business
AG Ellison Joins Suit to Block Surmodics Acquisition - Twin Cities Business
(SRDX) Long Term Investment Analysis - news.stocktradersdaily.com
Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System - Yahoo Finance
Surmodics launches Pounce XL for peripheral artery clot removal By Investing.com - Investing.com South Africa
Surmodics launches Pounce XL thrombectomy system - Yahoo Finance
Surmodics launches Pounce XL for peripheral artery clot removal - Investing.com Australia
Revolutionary Blood Clot Treatment: Pounce XL Shows 80% Success Rate in Just 20 Minutes - Stock Titan
Gardner Lewis Asset Management L P Raises Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Learn to Evaluate (SRDX) using the Charts - news.stocktradersdaily.com
PE Firm Hits Back Against Medical Device Coating Challenge - Law360
FTC Challenges Medical Device Coatings Deal - Medical Product Outsourcing
Zacks Research Decreases Earnings Estimates for Surmodics - Defense World
Bank of New York Mellon Corp Sells 2,966 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now - Zacks Investment Research
FTC’s First Merger Challenge Under New Leadership Signals Return to Traditional Antitrust Theories in Private Equity Deals - JD Supra
GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump - JD Supra
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics - Yahoo Finance
Medical Coating Market Projected To Witness Substantial Growth, 2025-2032: Freudenberg Medical Europe GmbH, - EIN News
Surmodics (NASDAQ:SRDX) Stock Rating Upgraded by Lake Street Capital - Defense World
Lake Street Upgrades Surmodics (SRDX) - Nasdaq
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge - MSN
Where are the Opportunities in (SRDX) - Stock Traders Daily
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private - Benzinga
FTC Sues to Block Sale of Surmodics - PlasticsToday
FTC targets GTCR in agency's first merger challenge under new Trump term - Crain's Chicago Business
FTC challenges private equity firm’s acquisition of Surmodics - MassDevice
FTC challenges $627M private equity takeover of Surmodics - MedTech Dive
Surmodics remains committed to GTCR merger despite US FTC suit - MLex
Why Surmodics Stock Is Falling On Friday - Benzinga India
Surmodics says it will defend proposed acquisition by GTCR against FTC lawsuit - pehub.com
Lake Street Upgrades SurModics to Buy From Hold, Price Target is $43 -March 07, 2025 at 08:46 am EST - Marketscreener.com
Surmodics Vows to Oppose FTC Decision to Block GTCR Deal -March 07, 2025 at 04:39 am EST - Marketscreener.com
Rhumbline Advisers Boosts Stake in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Surmodics contests FTC challenge to GTCR acquisition By Investing.com - Investing.com South Africa
Surmodics Responds To FTC Challenge, Commits To Completing Merger With GTCR - Nasdaq
US FTC sues to block private equity purchase of medical company - Reuters.com
Surmodics Says Disagrees With FTC's Decision And Remains Committed To Completing Merger with GTCR - Marketscreener.com
Surmodics contests FTC challenge to GTCR acquisition - Investing.com
Will FTC Block Surmodics' $627M Deal? Company Ready for Court Battle - StockTitan
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR - Business Wire
FTC Challenges PE Firm's Medical Device Coatings Deal - Law360
US FTC sues to block GTCR-Surmodics deal - MLex
FTC sues to block GTCR’s $627M Surmodics acquisition - Modern Healthcare
US FTC sues to block private equity buy of medical company -March 06, 2025 at 04:47 pm EST - Marketscreener.com
FTC Sues GTCR, Surmodics Over Medical Device Coatings Deal (1) - Bloomberg Law
FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics - Marketscreener.com
GTCR-Surmodics merger challenged by US FTC - MLex
FTC sues to block acquisition of Surmodics - TipRanks
Surmodics drops after FTC files suit to block its planned sale to GTCR (SRDX:NASDAQ) - Seeking Alpha
Surmodics Inc (SRDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
0.46%
자본화:
|
볼륨(24시간):